[
  {
    "ts": null,
    "headline": "Cardiovascular Surgical Devices Market Competitive Analysis Report 2025: Key Players, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts",
    "summary": "The cardiovascular surgical devices market is poised for growth, expected to rise from approximately $2.18 billion in 2025 to about $2.86 billion by 2033, at a 3.45% CAGR. Key factors driving this growth include increased cardiovascular disease rates, advances in surgical technology, and a shift towards minimally invasive procedures. Such developments are set to positively impact global cardiac healthcare. Prominent manufacturers, including Abbott, Boston Scientific, and Medtronic, continue to i",
    "url": "https://finnhub.io/api/news?id=eb9505c9f5e354b3b6eeb6affd67156d88e0d5832f9c41472c2cbfa42b650038",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769612880,
      "headline": "Cardiovascular Surgical Devices Market Competitive Analysis Report 2025: Key Players, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts",
      "id": 138281541,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "The cardiovascular surgical devices market is poised for growth, expected to rise from approximately $2.18 billion in 2025 to about $2.86 billion by 2033, at a 3.45% CAGR. Key factors driving this growth include increased cardiovascular disease rates, advances in surgical technology, and a shift towards minimally invasive procedures. Such developments are set to positively impact global cardiac healthcare. Prominent manufacturers, including Abbott, Boston Scientific, and Medtronic, continue to i",
      "url": "https://finnhub.io/api/news?id=eb9505c9f5e354b3b6eeb6affd67156d88e0d5832f9c41472c2cbfa42b650038"
    }
  },
  {
    "ts": null,
    "headline": "United States AI in Healthcare Market Forecast Report and Company Analysis 2025-2033 Featuring AWS, General Vision, Google, Intel, Medtronic, Micron, Microsoft, Next IT, NVIDIA, Siemens Healthcare",
    "summary": "The United States AI in Healthcare Market is projected to soar from US$ 10.26 billion in 2025 to US$ 99.77 billion by 2033, growing at a CAGR of 32.88%. This growth is driven by digital transformation, precision medicine demand, government support, and the need for cost-effective healthcare. AI applications like predictive analytics and medical imaging improve care efficiency and accuracy. The industry's expansion benefits from AI-enhanced clinical decision-making, personalized medicine, and NLP",
    "url": "https://finnhub.io/api/news?id=82bbb09a30e58fdbc0d9d21ccb133ad66470371850da5a81cba8237552c6a641",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769612760,
      "headline": "United States AI in Healthcare Market Forecast Report and Company Analysis 2025-2033 Featuring AWS, General Vision, Google, Intel, Medtronic, Micron, Microsoft, Next IT, NVIDIA, Siemens Healthcare",
      "id": 138281347,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "The United States AI in Healthcare Market is projected to soar from US$ 10.26 billion in 2025 to US$ 99.77 billion by 2033, growing at a CAGR of 32.88%. This growth is driven by digital transformation, precision medicine demand, government support, and the need for cost-effective healthcare. AI applications like predictive analytics and medical imaging improve care efficiency and accuracy. The industry's expansion benefits from AI-enhanced clinical decision-making, personalized medicine, and NLP",
      "url": "https://finnhub.io/api/news?id=82bbb09a30e58fdbc0d9d21ccb133ad66470371850da5a81cba8237552c6a641"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic Cardiac Tech And Mindray Partnership Underpin Neutral Valuation Story",
    "summary": "Medtronic (NYSE:MDT) received CE Mark approval in Europe for its Affera Sphere-360 pulsed field ablation catheter for cardiac ablation procedures. The company has started pivotal U.S. clinical trials for the Affera Sphere-360 system, including first-in-human procedures. Medtronic extended its partnership with Mindray to integrate Medtronic patient monitoring technology into ambulatory surgery centers. For investors watching Medtronic at a share price of $100.69, these product and...",
    "url": "https://finnhub.io/api/news?id=622608a467de97f3b85e6ee0201e833f250bf4b9960402792bbba6bbc3b64c2b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769609390,
      "headline": "Medtronic Cardiac Tech And Mindray Partnership Underpin Neutral Valuation Story",
      "id": 138281617,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic (NYSE:MDT) received CE Mark approval in Europe for its Affera Sphere-360 pulsed field ablation catheter for cardiac ablation procedures. The company has started pivotal U.S. clinical trials for the Affera Sphere-360 system, including first-in-human procedures. Medtronic extended its partnership with Mindray to integrate Medtronic patient monitoring technology into ambulatory surgery centers. For investors watching Medtronic at a share price of $100.69, these product and...",
      "url": "https://finnhub.io/api/news?id=622608a467de97f3b85e6ee0201e833f250bf4b9960402792bbba6bbc3b64c2b"
    }
  }
]